Hereditary hemorrhagic telangiectasia

MONDO:0019180

A disorder of angiogenesis leading to arteriovenous dilatations: cutaneo-mucosal hemorrhagic telangiectasias and visceral shunting.

Also known as: HHT, Osler-Weber-Rendu disease, Rendu-Osler disease, Rendu-Osler-Weber disease, hereditary hemorrhagic telangiectasia, telangiectasia, hereditary Hemorrahagic, of Rendu, Osler, telangiectasia, hereditary hemorrhagic

39 clinical trials for this condition and its sub-types, 34 tagged with Hereditary hemorrhagic telangiectasia itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Developmental defect during embryogenesis (1060) ↑ Autosomal dominant disease (699) ↑ Capillary malformation (49) ↑ Telangiectasis (45)

Sub-types of Hereditary hemorrhagic telangiectasia

Telangiectasia, hereditary hemorrhagic, type 1 4 trials
Hereditary hemorrhagic telangiectasia type 3 0 trials
Hereditary hemorrhagic telangiectasia type 4 0 trials
Telangiectasia, hereditary hemorrhagic, type 2 0 trials
Telangiectasia, hereditary hemorrhagic, type 5 0 trials

Including sub-types (39) Tagged with Hereditary hemorrhagic telangiectasia (34)

Trials to join now! 16 Not yet recruiting 2 Not yet finished but already full! 8 Completed 12 Terminated 1

Could a common heart drug tame nosebleeds in rare disease?

Symptom relief Stopped early

This study tested whether propranolol, a beta-blocker usually used for heart conditions, can reduce nosebleeds in people with hereditary hemorrhagic telangiectasia (HHT), a genetic disorder that causes abnormal blood vessels. Fifteen adults with HHT took either propranolol or a p…

Phase 3 • Sponsor: University Hospital, Bordeaux • Aim: Symptom relief

Last updated Jun 27, 2026 14:02 UTC

Hereditary hemorrhagic telangiectasia

Where it sits in the disease tree

Could a common heart drug tame nosebleeds in rare disease?